ACP Journal Club. Use of paroxetine during tamoxifen therapy for breast cancer was associated with increased breast-cancer and all-cause mortality

Affiliations

Comment

Bruce E Hillner. Ann Intern Med. 2010.

. 2010 Jun 15;152(12):JC6-13.

doi: 10.7326/0003-4819-152-12-201006150-02013.

No abstract available

Comment on

Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study.
Kelly CM, Juurlink DN, Gomes T, Duong-Hua M, Pritchard KI, Austin PC, Paszat LF. Kelly CM, et al. BMJ. 2010 Feb 8;340:c693. doi: 10.1136/bmj.c693. BMJ. 2010. PMID: 20142325 Free PMC article.

ACP Journal Club. Review: Tamoxifen, raloxifene, and tibolone prevent primary invasive breast cancer but increase risk for adverse outcomes.
Melnikow J. Melnikow J. Ann Intern Med. 2010 Mar 16;152(6):JC3-4. doi: 10.7326/0003-4819-152-6-201003160-02004. Ann Intern Med. 2010. PMID: 20231558 No abstract available.
ACP Journal Club. Meta-analysis: adjuvant tamoxifen reduces recurrence and death at 15 years in ER-positive early breast cancer.
Kiely B, Stockler M. Kiely B, et al. Ann Intern Med. 2012 Mar 20;156(6):JC3-4. doi: 10.7326/0003-4819-156-6-201203200-02004. Ann Intern Med. 2012. PMID: 22431690 No abstract available.
ACP Journal Club. Review: In women 39 to 69 years of age, screening with mammography reduces breast cancer mortality.
Willett LR. Willett LR. Ann Intern Med. 2010 Feb 16;152(4):JC-27. doi: 10.7326/0003-4819-152-4-201002160-02007. Ann Intern Med. 2010. PMID: 20157131 No abstract available.
Tamoxifen, cytochrome P450 genes and breast cancer clinical outcomes.
Singh MS, Francis PA, Michael M. Singh MS, et al. Breast. 2011 Apr;20(2):111-8. doi: 10.1016/j.breast.2010.11.003. Epub 2010 Dec 24. Breast. 2011. PMID: 21185724 Review.
Tamoxifen therapy in breast cancer control worldwide.
Love RR, Koroltchouk V. Love RR, et al. Bull World Health Organ. 1993;71(6):795-803. Bull World Health Organ. 1993. PMID: 8313498 Free PMC article. Review.